Hemafer

Hemafer is an oral iron supplement marketed in the European Union. Its active ingredient is elemental iron, provided in a strength and dosage form. As a product, Hemafer is intended to support hemoglobin synthesis and erythropoiesis in individuals with iron deficiency. The formulation is designed for oral administration and follows EU regulatory standards for supplements. It is available without a prescription and may be used as part of a plan.

Hemafer is used to address iron deficiency and its clinical consequences.

- Treatment of iron deficiency anemia in adults and adolescents. - Prevention of iron deficiency in individuals with increased physiological needs, such as during growth, menstruation, or pregnancy. - Support for people following vegetarian or vegan diets who may have limited dietary iron intake. - Adjunct therapy for patients experiencing chronic blood loss, for example after surgery or gastrointestinal bleeding. - Supplementation in individuals with malabsorption syndromes that affect iron uptake.

Oral iron supplementation can be associated with a range of side effects, most of which are mild and transient.

Common: - Gastrointestinal discomfort such as nausea, abdominal cramping, or bloating. - Constipation or, less frequently, loose stools. - Darkening of the stool color, which is harmless. - Metallic taste in the mouth.

Serious: - Severe allergic reaction manifesting as rash, itching, swelling, or difficulty breathing. - Signs of iron overload such as persistent vomiting, abdominal pain, or joint pain. - Unexplained fatigue or weakness that does not improve with therapy.

Before starting Hemafer, certain precautions should be considered to ensure safe and effective use.

- Verify iron deficiency through appropriate laboratory testing before supplementation. - Use caution in individuals with known hypersensitivity to iron preparations. - Avoid use in patients with hereditary hemochromatosis or other iron‑overload disorders. - Monitor for gastrointestinal side effects and adjust dosage or formulation if needed. - Discuss use with a healthcare professional during pregnancy, lactation, or when planning pregnancy. - Consider potential interactions with other medications and supplements. - Keep out of reach of children to prevent accidental ingestion.

Iron can affect the absorption and efficacy of several other medicines and nutrients.

Avoid: - Concurrent use with tetracycline or quinolone antibiotics, which may reduce the effectiveness of either agent. - Simultaneous intake with calcium‑containing antacids or supplements, as calcium interferes with iron absorption.

Use with caution: - Levothyroxine therapy, as iron may diminish its absorption; separate dosing by at least 4 hours. - Bisphosphonates for osteoporosis, which should be taken at a different time to avoid reduced absorption. - Certain multivitamins or mineral supplements containing zinc or copper, which may compete for absorption pathways.